We've now got a little more information on AstraZeneca's (AZN) halt to its coronavirus trials that was announced yesterday. Today it's clearer that the halt will be not just in the U.K. where one participant developed what could be a adverse reaction to the vaccine. The New York Times reported today that a person familiar with […]
To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the site. And we'll throw in the first week free! If you change your mind during that first week, just cancel your subscription from your profile page, and you won't be billed anything.
